Allergan Plc
(NYSE : AGN)

( )
AGN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
-0.21%160.912.9%$684.43m
ZTSZoetis, Inc. Class A
-0.83%126.581.9%$246.19m
MYLMylan N.V.
-0.26%19.043.2%$195.52m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
-2.69%7.252.0%$166.98m
TXMDTherapeuticsMD, Inc.
0.72%2.8024.9%$10.76m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
0.43%35.202.0%$8.17m
TAROTaro Pharmaceutical Industries Ltd.
-0.24%80.556.4%$2.96m
KINKindred Biosciences, Inc.
-3.46%7.530.3%$1.57m
JAGXJaguar Animal Health, Inc.
-7.81%1.189.8%$1.45m
ABEOAbeona Therapeutics, Inc.
-7.27%2.047.6%$1.36m
LFVNLifeVantage Corporation
0.94%11.863.3%$0.90m
CPHIChina Pharma Holdings, Inc.
0.58%0.260.1%$0.04m

Company Profile

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.